Inflammatory response linked to oxazolone-indued cutaneous basophil hypersensitivity: effect of different immunomodulator and anti-inflammatory drugs.

The potency of cytostatic and anti-inflammatory drugs was tested on the oxazolone-induced cutaneous basophil hypersensitivity (CBH) in mice. The challenge reaction was performed early after sensitization in order to minimize B-cell expression; exudative and cellular infiltration was estimated 6 h, 24 h and 48 h after challenge. The potency of drugs was tested at three different periods of immunization: 2 days before or after sensitization or before challenge.

Delayed hypersensitivity to mono-azobenzene arsonate-N-acetyl-L-tyrosine. II. An operational model in the mouse.

Immunization of the mouse by free mono-ABA-Tyrosine (ABA-Tyr) in complete Freund's adjuvant leads to a specific sensitization. This can be assessed by increase in ear thickness after challenge with ABA-Protein conjugates. The intensity of the skin reaction is directly related to both the antigen dosage and the amount of BCG incorporated in the adjuvant.

Delayed hypersensitivity to mono-azobenzene-arsonate-N-acetyl-L-tyrosine. I. Induction of cellular sensitivity in the rat.

In the guinea pig, mono-ABA-Tyrosone (ABA-Tyr) has been extensively studied as a hapten capable of inducing delayed type hypersensitivity in the absence of circulating antibodies. This model has been extented to the rat, and cellular sensitivity has been assessed both "in vivo" (skin reaction) and "in vitro" (cellular proliferation and lymphocyte migration inhibition). All the reactions studied follow a reproducible pattern with maximal positivity between 4 and 13 days, and negative responses after 20 days.